Cynosure Group LLC Invests $500,000 in Ventas, Inc. $VTR

Cynosure Group LLC purchased a new position in shares of Ventas, Inc. (NYSE:VTR) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 6,461 shares of the real estate investment trust’s stock, valued at approximately $500,000.

A number of other large investors have also modified their holdings of the business. GoalVest Advisory LLC purchased a new stake in Ventas in the fourth quarter valued at approximately $26,000. Wiser Advisor Group LLC purchased a new stake in Ventas in the third quarter valued at approximately $27,000. IFC & Insurance Marketing Inc. purchased a new stake in Ventas in the fourth quarter valued at approximately $30,000. Elyxium Wealth LLC purchased a new stake in Ventas in the fourth quarter valued at approximately $33,000. Finally, Manchester Capital Management LLC boosted its position in Ventas by 60.5% in the fourth quarter. Manchester Capital Management LLC now owns 491 shares of the real estate investment trust’s stock valued at $38,000 after buying an additional 185 shares during the last quarter. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Ventas Trading Up 0.5%

Shares of NYSE:VTR opened at $83.85 on Wednesday. Ventas, Inc. has a 12-month low of $61.76 and a 12-month high of $91.06. The company has a market capitalization of $40.76 billion, a PE ratio of 152.46, a PEG ratio of 1.80 and a beta of 0.71. The business has a 50 day moving average of $85.16 and a two-hundred day moving average of $82.56. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95.

Ventas (NYSE:VTR) last announced its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period in the previous year, the firm posted $0.84 earnings per share. The company’s revenue was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, analysts forecast that Ventas, Inc. will post 3.88 EPS for the current year.

Ventas Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be issued a $0.52 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. Ventas’s payout ratio is presently 378.18%.

Analyst Ratings Changes

A number of equities research analysts recently commented on VTR shares. BMO Capital Markets reiterated an “outperform” rating and issued a $100.00 target price on shares of Ventas in a research report on Monday, May 4th. KeyCorp upped their target price on Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. Jefferies Financial Group upped their target price on Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday, May 12th. The Goldman Sachs Group reiterated a “buy” rating and issued a $110.00 target price on shares of Ventas in a research report on Tuesday, May 19th. Finally, Scotiabank upped their target price on Ventas from $93.00 to $95.00 and gave the company a “sector perform” rating in a research report on Thursday, May 21st. Fifteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Ventas currently has a consensus rating of “Moderate Buy” and a consensus price target of $96.41.

Insider Buying and Selling

In other Ventas news, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the transaction, the director directly owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler purchased 2,500 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The stock was bought at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the acquisition, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. The SEC filing for this purchase provides additional information. Insiders own 0.53% of the company’s stock.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.